N04BC05 - Pramipexole |
Propably not porphyrinogenic |
PNP |
Rationale
Mainly excreted in unchanged form.
Chemical description
(To be edited, initial data ST OCT 04) Dopamine agonist used to improve motoric function in Parkinson´s disease. More than 90 % excreted in unchanged form by the kidneys. No data pointing to CYP-interaction.
IPNet drug reports
Uneventful use reported in 1 patients with acute porphyria.
Similar drugs
© NAPOS 2024